ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT

Objective: T-cell prolymphocytic leukemia (T-PLL) is a rare and highly aggressive T cell neoplasm with rapidly progressing clinical course. T-PLL accounts for 2% of mature lymphocytic leukemia in adults. Median overall survival with modern therapy is reported one to three years. Here we report a T-P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Senem MARAL, Murat ALBAYRAK, Hacer Berna OZTURK, MerihREIS ARAS, Fatma YILMAZ, Pınar TIGLIOGLU, Mesut TIGLIOGLU, Buğra SAGLAM
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/39d3aa3066d64189aaf2033276fee2f5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!